PATENT CLAIM ANALYSIS

Application Number: 15743418
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "400000"]

Abstract:
Methods for enhancing the bioavailability of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride (ATR-101) through administration with food, and compositions and kits related thereto.

Claim (Index 26):
The solid pharmaceutical composition of  claim 17 , wherein ATR-101 has a particle size distribution ranging from 10 to 14 \u03bcm.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.4375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15370980', '14866212', '15170682', '14798237', '13802047']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7449619174242059
- 35 USC 102 Novelty (BERT): 0.5224399954736374
- Combined Prediction Score: 0.722709725229149
- Mean Citation Score: 252.78427
- Max Citation Score: 301.74615
- Similarity Product: 183.6883961473167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test